Nxera Pharma Webinar Presentation for FY2024 Financial Results

Earnings Announcement and Webinar - Nxera Pharma will announce its earnings results and operational highlights for the year ended 31 December 2024 on 14 February 2025 [1] - The company will host a live webinar presentation on 14 February 2025 at 5:00 pm JST (8:00 am GMT) featuring key executives including the President and CEO, CFO, and heads of UK and Japan operations [2] - The webinar is open to all existing and potential investors as well as sell-/buy-side analysts and will include a presentation followed by a Q&A session [3] - Presentation slides will be available by 4:30 pm JST (7:30 am GMT) on 14 February 2025 through the investor section of the company's website [3] Company Overview - Nxera Pharma is a technology-powered biopharma company focused on developing new specialty medicines to improve the lives of patients with unmet needs in Japan and globally [3] - The company has over 30 active programs in its pipeline, ranging from discovery to late clinical stage, addressing major unmet needs in neurology, GI and immunology, metabolic disorders, and rare diseases [4] - Nxera Pharma employs over 350 people across key locations in Tokyo, Osaka, London, Cambridge, Basel, and Seoul [5] Pipeline and Technology - The company's pipeline leverages its unique and industry-leading GPCR-targeted structure-based drug discovery platform, NxWave™, to develop best- or first-in-class candidates [4] - Nxera Pharma is advancing its pipeline both internally and in partnership with leading pharma and biotech companies [4] - Several products are already being commercialized in Japan [4]